American burn association practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients

Journal of Burn Care and Research

Volumn 30, Issue 6, 2009, Pages 910-928

  Mosier, Michael J ^a   Pham, Tam N ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEFTAZIDIME; CHLORHEXIDINE; COTRIMOXAZOLE; GENTAMICIN; INSULIN; LINEZOLID; SULBACTAM; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BURN; BURN PATIENT; CLINICAL TRIAL; CONTINUOUS INFUSION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; EVIDENCE BASED MEDICINE; HOSPITAL INFECTION; HUMAN; HYPOGLYCEMIA; INFECTION CONTROL; MEDICAL SOCIETY; NONHUMAN; PRACTICE GUIDELINE; PULMONARY CANDIDIASIS; RATING SCALE; RESPIRATORY TRACT INFECTION; REVIEW; TRACHEOSTOMY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA; ADULT; ARTICLE; BLOOD TRANSFUSION; CROSS INFECTION; INSTRUMENTATION; METHODOLOGY; RISK FACTOR; TIME;

ADULT; ANTIBIOTIC PROPHYLAXIS; BLOOD TRANSFUSION; BURNS; CROSS INFECTION; EVIDENCE-BASED MEDICINE; HUMANS; INSULIN; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RISK FACTORS; TIME FACTORS; TRACHEOSTOMY;

EID: 75349085716     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181bfb68f     Document Type: Review

References (258)

1. Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53:1-36.
2. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) manual: patient safety component protocol 2007; available from: http:// www.cdc.gov/ncidod/dhqp/pdf/nhsn/NHSN- Manual- PatientSafetyProtocol-CURRENT.pdf; Internet; accessed December 14, 2008.
3. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequnces of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184-2193
4. Rello J, Ollendorf D, Oster G, et al; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121
5. Santucci S, Gobara S, Santos C, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 2003;53:6-13.
6. Wibbenmeyer L, Danks R, Faucher L, et al. Prospective analysis of nosocomial infection rates, antibiotic use, and patterns of resistance in a burn population. J Burn Car Res 2006;27: 152-160
7. Lazarus H, Fox J, Lloyd J, et al. A six-year descriptive study of hospital-associated infection in trauma patients: demograph- ics, injury features, and infection patterns. Surg Infect (Larchmt) 2007;8:463-473
8. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R; CDC; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1-36.
9. Cook D, Walter S, Cook R, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440 (Pubitemid 28428078)
10. Bahrani-Mougeot F, Paster B, Coleman S, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol 2007;45:1588-1593
11. DeRiso AJ II, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996;109:1556-1561
12. Seguin P, Tanguy M, Laviolle B, Tirel O, Mallédant Y. Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma. Crit Care Med 2006;34:1514-1519
13. Bonten MJ, Gaillard CA, de Leeuw PW, Stobberingh EE. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis 1997;24:309-319
14. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
15. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-288
16. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical ICUs in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-892
17. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilatorassociated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-539
18. Eckert M, Davis K, Reed RL II, et al. Ventilator-associated pneumonia, like real estate: location really matters. J Trauma 2006;60:104-10; discussion 110.
19. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333:817-822
20. Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998;339:429-435 (Pubitemid 28377684)
21. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001;344: 817-822
22. Celis R, Torres A, Gatell JM, Almela M, Rodríguez-Roisin R, Agustí-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988;93:318-324
23. Pham TN, Cho K, Adamson LK, et al. Burn injury induces an inhibitory signal in the lung Smad pathway. Cytokine 2004; 27:66-73.
24. Patel PJ, Faunce DE, Gregory MS, Duffner LA, Kovacs EJ. Elevation in pulmonary neutrophils and prolonged production of pulmonary macrophage inflammatory protein-2 after burn injury with prior alcohol exposure. Am J Respir Crit Care Med 1999;20:1229-1237
25. Harms BA, Bodai BI, Kramer GC, Demling RH. Microvascular fluid and protein flux in pulmonary and systemic circulations after thermal injury. Microvasc Res 1982;23:77-86.
26. Carajal HF, Linares HA, Brouhard BH. Relationship of burn size to vascular permeability changes in rats. Surg Gynecol Obstet 1979;149:193-202.
27. Ward PA, Till GO. Pathophysiologic events related to thermal injury of skin. J Trauma 1990;30:S75-9.
28. Rodriguez JL, Miller CG, Garner WL, et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684-94; discussion 694-695
29. Edelman DA, Khan N, Kempf K, White MT. Pneumonia after inhalation injury. J Burn Car Rehabil 2007;28:241-246
30. Smith DL, Cairns BA, Ramdan F, et al. Effect of inhalation injury, burn size, and age on mortality: a study of 1447 consecutive burn patients. J Trauma 1994;37:655-659
31. Shirani KZ, Pruitt B Jr, Mason AD Jr. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987;205:82-87
32. Sellersk BJ, Davis BL, Larkin PW, Morris SE, Saffle JR. Early prediction of prolonged ventilator dependence in thermally injured patients. J Trauma 1997;43:899-903.
33. Tredget EE, Shankowsky HA, Taerum TV, Moysa GL, Alton JD. The role of inhalation injury in burn trauma. A Canadian experience. Ann Surg 1990;212:720-727
34. Kimura R, Traber LD, Herndon DN, Linares HA, Lubbesmeyer HJ, Traber DL. Increasing duration of smoke exposure induces more severe lung injury in sheep. J Appl Physiol 1988;64:1107-1113
35. Haponik E. Clinical smoke inhalation injury: pulmonary effects. Occup Med 1993;8:430-468
36. Abdi S, Evans MJ, Cox RA, Lubbesmeyer H, Herndon DN, Traber DL. Inhalation injury to tracheal epithelium in an ovine mofel of cotton smoke exposure. Early phase (30 minutes). Am Rev Respir Dis 1990;142:1436-1439
37. Linares HA, Herndon DN, Traber DL. Sequence of morphologic events in experimental smoke inhalation. J Burn Car Rehabil 1989;10:27-37.
38. Stothert JC Jr, Ashley KD, Kramer GC, et al. Intrapulmonary distribution of bronchial blood flow after moderate smoke inhalation. J Appl Physiol 1990;69:1734-1739
39. Abdi S, Herndon DN, McGuire J, Traber L, Traber DL. Time course of alterations in lung lymph and bronchial blood flows after inhalation injury. J Burn Car Rehabil 1990;11: 510-515
40. Ramzy PI, Barret JP, Herndon DN. Thermal injury. Crit Care Clin 1999;15:333-352
41. Soejima K, Schmalstieg FC, Sakurai H, Traber LD, Traber DL. Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 2001;280:L1233-41.
42. Cox RA, Burke AS, Soejima K, et al. Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol 2003;29:295-302.
43. Herndon DN, Traber LD, Linares H, et al. Etiology of the pulmonary pathophysiology associated with inhalation injury. Resuscitation 1986;14:43-59.
44. Traber DL, Herndon DN, Stein MD, Traber LD, Flynn JT, Niehaus GD. The pulmonary lesion of smoke inhalation in an ovine model. Circ Shock 1986;18:311-323
45. Hales CA, Barkin P, Jung W, Quinn D, Lamborghini D, Burke J. Bronchial artery ligation modifies pulmonary edema after exposure to smoke with acrolein. J Appl Physiol 1989; 67:1001-1006
46. Kraneveld AD, Nijkamp FP. Tachykinins and neuro-immune interactions in asthma. Int Immunopharmacol 2001;1: 1629-1650
47. Virág L. Poly (ADP-ribosyl)ation in asthma and other lung diseases. Pharmacol Res 2005;52:83-92.
48. Soejima K, Traber LD, Schmalstieg FC, et al. Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am J Respir Crit Care Med 2001; 163:745-752 (Pubitemid 32230839)
49. Traber DL, Schlag G, Redl H, Traber LD. Pulmonary edema and compliance changes following smoke inhalation. J Burn Car Rehabil 1985;6:490-494
50. Youn YK, LaLonde C, Demling R. Oxidants and the pathophysiology of burn and smoke inhalation injury. Free Radic Biol Med 1992;12:409-415
51. Niehaus GD, Kimura R, Traber LD, Herndon DN, Flynn JT, Traber DL. Administration of a synthetic antiprotease reduces smoke-induced lung injury. J Appl Physiol 1990;69: 694-699
52. Nieman GF, Clark WR Jr. Effects of wood and cotton smoke on the surface properties of pulmonary surfactant. Respir Physiol 1994;97:1-12.
53. Wright MJ, Murphy JT. Smoke inhalation enhances early alveolar leukocyte responsiveness to endotoxin. J Trauma 2005;59:64-70.
54. Klein MB, Hayden D, Elson C, et al. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg 2007;245:622-628
55. Chastre J, Trouillet JL, Vaugnat A, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157:1165-1172
56. Wunderink RG, Waterer GW. Pneumonia complicating the acute respiratory distress syndrome. Semin Respir Crit Care Med 2002;23:443-448
57. Iregui M, Kollef M. Ventilator-associated pneumonia complicating the acute respiratory distress syndrome. Semin Respir Crit Care Med 2001;22:317-326
58. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome. Incidence and diagnosis. Am J Respir Crit Care Med 1997;156:1092-1098
59. Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome: a prospective evaluation of bilateral bronchoscopic sampling. Am J Respir Crit Care Med 1998;158:870-875
60. Sutherland KR, Steinberg KP, Maunder RJ, Milberg JA, Allen DL, Hudson LD. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:550-556
61. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99:293-298
62. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000;161:1942-1948
63. Fagon JY, Chastre J. Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients. Eur Respir J Suppl 2003; 42:77s-83.
64. Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid CR. Nosocomial infections in surgical patients in the United States, January 1986-June1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 1993;14:73-80.
65. Torres A, Gatell JM, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995;152: 137-141
66. Cook D, De Jonghe B, Brochard L, Brun-Buisson C. Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. JAMA 1998; 279:781-787
67. De Bast Y, De Baker D, Moraine JJ, Lemaire M, Vandenborght C, Vincent JL. The cuff leak test to predict failure of tracheal extubation for laryngeal edema. Intensive Care Med 2002;28:1267-1272
68. Sandhu RS, Pasquale MD, Miller K, Wasser TE. Measurement of endotracheal tube cuff leak to predict post extubation stridor and need for reintubation. J Am Coll Surg 2000;190: 682-687
69. Fisher MM, Raper RF. The 'cuff-leak' test for extubation. Anaesthesia 1992;47:10-12
70. Kriner EJ, Shafazand S, Colice GL. The endotracheal tube cuff-leak test as a predictor for postextubation stridor. Respir Care 2005;50:1632-1638
71. Craven DE, Steger KA. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect 1996;11:32-53.
72. Weinstein R. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991;91: 179S-84.
73. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996;335: 1864-1869
74. Kollef MH, Shapiro SD, Silver P, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 1997; 25:567-574
75. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.NEngl J Med 2000;342:1471-1477
76. Robertson TE, Sona C, Schallom L, et al. Improved extubation rates and earlier liberation from mechanical ventilation with implementation of a daily spontaneous-breathing trial protocol. J Am Coll Surg 2008;206:489-495
77. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008;371:126-134
78. Esteban A, Alia I, Tobin MJ, et al. Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999;159:512-518
79. Vallés J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995;179-186
80. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992;18:20-25
81. Kollef MH, Skubas N, Sundt TM. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999;116:1339-1346
82. Pneumatikos I, Koulouras V, Nathanail C, Goe D, Nakos G. Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma. Intensive Care Med 2002;28:432-437
83. Ramirez P, Ferrer M, Torres A. Prevention measures for ventilator-associated pneumonia: a new focus on the endotracheal tube. Curr Opin Infect Dis 2007;20:190-197
84. Smulders K, van der HoevenH,Weers-Pothoff I, Vandenbroucke- Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest 2002;121:858-862
85. Petering HG. Pharmacology and toxicology of heavy metals: silver. Pharmacol Ther 1976;1:127-130
86. Ahearn DG, Grace DT, Jennings MJ, et al. Effects of hydrogel/ silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol 2000;41:120-125
87. Gabriel MM, Sawant AD, Simmons RB, Ahearn DG. Effects of silver on adherence of bacteria to urinary catheters in vitro studies. Curr Microbiol 1995;30:17-22.
88. Berra L, De Marchi L, Yu ZX, Laquerriere P, Baccarelli A, Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology 2004;100:1446-1456
89. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associtated pneumonia, The NASCENT randomized trial. JAMA 2008;300: 805-813
90. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354:1851-1858
91. Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition in patients receiving mechanical ventilation: multiple sources of tracheal colonization include the stomach. Am J Med 1986; 80:827-832
92. Davis K Jr, Johannigman JA, Campbell RS, et al. The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury. Crit Care 2001;5: 81-87
93. Orozco-Levi M, Torres A, Ferrer M, et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal relux in mechanically ventilated patients. Am J Respir Crit Care Med 1995;152: 1387-1390
94. Torres A, Serra-Batlles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992;116: 540-543
95. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 1994;120: 653-662
96. Bonten MJ, Gaillard CA, van der Geest S, et al. The role of intragastric acidity and stress ulcer prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am J Respir Crit Care Med 1995;152:1825-1834
97. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998;338: 791-797
98. Dissanaike S, Pham T, Shalhub S, et al. Effect of immediate enteral feeding on trauma patients with an open abdomen: protection from nosocomial infections. JACS 2008;207: 690-697
99. Heyland DK, Drover GW, MacDonald S, Novak F, Lam M. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med 2001;29:1495-1501
100. Ho KM, Dobb GJ, Webb SA. A comparison of early gastric and post-pyloric feeding in critically ill patients: a metaanalysis. Intensive Care Med 2006;32:639-649
101. Abele-Horn M, Dauber A, Bauernfeind A, et al. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med 1997;23:187-195
102. Bergmans DC, Bonten MJ, Gaillard CA, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001;164:382-388
103. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia: a randomized, placebo controlled, double-blind clinical trial. JAMA 1991;265:2704-2710
104. Rodriguez-Roldan JM, Altuna-Cyesta A, Lopez A, et al. Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med 1990;18:1239-1242
105. Silvestri L, van Saene HK, Thomann C, Perić M. Selective decontamination of the digestive tract reduces pneumonia and mortality without resistance emerging. Am J Infect Control 2007;35:354-357
106. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2004:CD000022.
107. Barret JP, Jeschke MD, Herndon DN. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001;27:439-445
108. de la Cal MA, Cerda E, Garcia-Hierro P, et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebocontrolled, double-blind trial. Ann Surg 2005;241:424-430
109. Kimura A, Mochizuki T, Nishizawa K, Mashiko K, Yamamoto Y, Otsuka T. Trimethoprim-sulfamethoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients. J Trauma 1998;45: 383-387
110. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med 1992;326:594-599
111. Hammond JMJ, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992;340:5-9.
112. Wiener J, Itozaku G, Nathan C, Kabins SA, Weinstein RA. A randomized, double-blind placebo-controlled trial of selective decontamination in a medical-surgical intensive care unit. Clin Infect Dis 1995;20:861-867
113. Lingnau W, Berger J, Javorsky F, Fille M, Allerberger F, Benzer H. Changing bacterial ecology during a five year period of selective intestinal decontamination. J Hosp Infect 1998;39:195-206.
114. Verwaest C, Verhaegen J, Ferdinande P, et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997;25:63-71.
115. Misset B, Kitzis M, Mahe P, et al. Bacteriological side effects of gut decontamination with polymixen E, gentamycin, and amphotericin B. Infect Control Hosp Epidemiol 1993;13: 62-64
116. Misset B, Kitzis M, Conscience G, Goldstein F, Fourrier A, Carlet J. Mechanisms of failure to decontaminate the gut with polymixen E, gentamycin, and amphotericin B in patients in intensive care. Eur J Clin Microbiol Infect Dis 1994;13: 165-170
117. van Saene HK, Petros AJ, Ramsay G, Baxby D. All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 2003;29:677-690
118. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% cholhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002;11: 567-570
119. Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexadine reduces the incidence of ventilatorassociated pneumonia. Am J Respir Crit Care Med 2006;173: 1348-1355
120. Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 2007; 334:889.
121. Chlebicki MP, Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007;35:595-602.
122. Kola A, Gastmeier P. Efficacy of oral chlorhexadine in preventing lower respiratory tract infections. Meta-analysis of randomized controlled trials. J Hosp Infect 2007;66: 207-216
123. Fourrier F, Dubois D, Pronnier P, et al. Effect of gingival and dental plaque antiseptic decontamination on nosocomial in- fections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit Care Med 2005; 33:1728-1735
124. Alexander J. Mechanism of immunologic suppression in burn injury. J Trauma 1990;30:S70-5.
125. Munster A. Alterations of the host defense mechanism in burns. Surg Clin North Am 1970;50:1217-1225
126. Shorr A, Duh M, Kelly K, Kollef MH; CRIT Study Group. Red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit Care Med 2004;32: 666-674
127. Palmieri TL, Caruso DM, Foster KN, et al; American Burn Association Burn Multicenter Trials Group. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med 2006;34:1602-1607
128. Leal-Noval SR, Rincon-Ferrari MD, Gaarcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001; 2001:1461-1468
129. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997;44:1256-1261
130. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 2006;103:15-20.
131. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367
132. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190-3197
133. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis.NEngl J Med 2008; 358:125-139
134. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery 2008;144: 629-635
135. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000;356: 1307-1312
136. Kollef MH, Shapiro SD, Fraser VJ, et al. Mechanical ventilation with or without 7-day circuit changes: a randomized controlled trial. Ann Intern Med 1995;123:168-174
137. Dreyfus D, Djedaini K, Weber P, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis 1991;143: 738-743
138. Craven DE, Goularte TA, Make BJ. Contaminated condensate in mechanical ventilator circuits: a risk factor for nosocomial pneumonia? Am Rev Respir Dis 1984;129:625-628
139. Hess D. Prolonged use of heat and moisture exchangers: why do we keep changing things? Crit Care Med 2000;28: 1667-1668
140. Kollef MH, Shapiro SD, Boyd V, et al. A randomized clinical trial comparing an extended-use hygroscopic condenser humidifier with heated-water humidification in mechanically ventilated patients. Chest 1998;113:759-767 (Pubitemid 28130954)
141. Landrum ML, Murray CK. Ventilator associated pneumonia in a military deployed setting: the impact of an aggressive infection control program. J Trauma 2008;64:S123-7.
142. Bonello RS, Fletcher CE, Becker WK, et al. An intensive care unit quality improvement collaborative in nine Department of Veterans Affairs hospitals: reducing ventilator-associated pneumonia and catheter-related bloodstream infection rates. Jt Comm J Qual Patient Saf 2008;34:639-645
143. DuBose JJ, Inaba K, Shiflett A, et al. Measurable outcomes of quality improvement in the trauma intensive care unit: the impact of a daily quality rounding checklist. J Trauma 2008; 64:22-27
144. Ogaard JL, Johnston MJ, Cain T, et al. Ventilator-associated pneumonia in the burn center population-does bundle compliance make a difference? J Burn Car Res 2008;29:S99.
145. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
146. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;335:2619-2630
147. Kollef M. Diagnosis of ventilator-associated pneumonia. N Engl J Med 2006;355:2691-2692
148. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988;138:110-116
149. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121-1129
150. Singh N, Falestiny MN, Rogers P, et al. Pulmonary infiltrates in the surgical ICU. Prospective assessment of predictors of etiology and mortality. Chest 2000;114:1129-1136
151. Croce M, Swanson J, Magnotti L, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma 2006;60:523-7; discussion 527-528
152. Pham T, Neff M, Simmons J, Gibran NS, Heimbach DM, Klein MB. The clinical pulmonary infection score poorly predicts pneumonia in patients with burns. J Burn Care Res 2007;28:76-79
153. Croce M, Fabian T, Schurr M, et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis. J Trauma 1995;39:1134-9, discussion 1139-1140
154. Luyt CE, Chastre J, Fagon JY. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med 2004;30:844-852
155. Chastre J, Fagon JY. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia. Am J Respir Crit Care Med 1994;150:570-574
156. Chastre J, Fagon JY. Diagnosis of ventilator-associated pneumonia. N Engl J Med 2007;356:1469-1470
157. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000;132: 621-630
158. Wahl W, Ahrns K, Brandt M, Rowe SA, Hemmila MR, Arbabi S. Bronchoalveolar lavage in diagnosis of ventilatorassociated pneumonia in patients with burns. J Burn Care Rehabil 2005;26:57-61.
159. Kollef MH, Ward S. The influence of Mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113: 412-420
160. Silver G, Klein M, Herndon D, et al; Inflammation and the Host Response to Trauma, Collaborative Research Program. Standard operating procedures for the clinical management of patients enrolled in a prospective study of Inflammation and the Host Response to Thermal Injury. J Burn Care Res 2007;28:222-230
161. Croce M, Fabian T, Mueller E, et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma 2004;56:931-4; discussion 934-936
162. Minei JP, Nathans AB, West M, et al; Inflammation and the Host Response to Injury Large Scale Collaborative Research Program Investigators. Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core-standard operating procedures for clinical care. II. Guidelines for prevention, diagnosis and treatment of ventilator-associated pneumonia (VAP) in the trauma patient. J Trauma 2006;60:1106-1113 (Pubitemid 43778650)
163. Croce MA, Fabian TC, Mueller EW, et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative culture. J Trauma 2004;56:931-934
164. Miller P, Meredith J, Chang M. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage. J Trauma 2003;55:263-7; discussion 267-268
165. Barret JP, Ramzy PI, Wolf SE, Herndon DN. Sensitivity and specificity of bronchoalveolar lavage and protected bronchial brush in the diagnosis of pneumonia in pediatric burn patients. Arch Surg 1999;134:1243-1247
166. Chastre J, Fagon JY, Bornet-Lesco M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995;152:231-240
167. Johanson WG Jr, Seidenfeld JJ, Gomez P, de los Santos R, Coalson JJ. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis 1998;137:259-264
168. Marik PE, Baram M. Diagnosis of ventilator-associated pneumonia. N Engl J Med 2007;356:1470.
169. Mosier M, Gamelli R, Halerz M, Silver G. Microbial contamination in burn patients undergoing urgent intubation as part of their early airway management. J Burn Care Res 2008;29: 304-310
170. Low D. Resistance issues and treatment implications: Pneumococcus, Staphylococcus aureus, and Gram-negative rods. Infect Dis Clin North Am 1998;12:613-630
171. Carter JE, Miller PR III, Holmes JH IV. An epidemiologic study of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res 2008;29:S98.
172. Cabello H, Torres A, Celiss R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung diseases: a bronchoscopic study. Eur Respir J 1997;10:1137-1144 (Pubitemid 27201822)
173. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 2003;51:247-352.
174. Bradford P. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistant threat. Clin Microbiol Rev 2001;14: 933-951
175. Nordmann P, Poirel L. Emerging carbapenemases in Gramnegative aerobes. Clin Microbiol Infect 2002;8:321-331
176. Wood G, Hanes S, Croce M, Fabian TC, Boucher BA. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis 2002;34:1425-1430
177. Chim H, Tan B, Song C. Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumannii in a tropical climate. Burns 2007;33:1008-1014
178. Combes A, Luyt CE, Fagon JY, et al; PNEUMA Trial Group. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 2004;170:786-792 (Pubitemid 39298995)
179. Vandenesch F, Naimi T, Enright MC, et al. Communityacquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-984
180. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton- Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002;359: 753-759
181. Fridkin SK, Hageman J, McDougal LK, et al; Vancomycin- Intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States 1997-2001. Clin Infect Dis 2003;36:429-439
182. Chang S, Sievert DM, Hageman JC, et al; Vancomycinresistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-1347
183. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358: 207-208
184. Lam AP, Wunderink RG. Methicillin-resistant S. aureus ventilator-associated pneumonia: strategies to prevent and treat. Semin Respir Crit Care Med 2006;27:92-103.
185. El-Ebiary M, Torres A, Fabregas N, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. Am J Respir Crit Care Med 1997;156:583-590
186. Krasinski K, Holzman RS, Hanna B, Greco MA, Graff M, Bhogal M. Nosocomial fungal infection during hospital renovation. Infect Control 1985;6:278-282
187. Lentino JR, Rosenkranz MA, Michaels JA, Kurup VP, Rose HD, Rytel MW. Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 1982;116: 430-437
188. Sarubbi FA Jr, Kopf HB, Wilson MB, McGinnis MR, Rutala WA. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am J Rev Respir Dis 1982;125:33-38
189. Gage AA, Dean DC, Schimert G, Minsley N. Aspergillus infection after cardiac surgery. Arch Surg 1970;101:384-387
190. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268
191. Garnacho-Montero J, Garcia-Garmendia JL, Barrero- Almodovar A, et al. Impact of the outcome of adequate empirical antibiotherapy in patients admitted to the ICU for sepsis. Crit Care Med 2003;31:2742-2751
192. Leone M, Burgoin A, Cambon S, Dubuc M, Albanèse J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003;31:462-467
193. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676-685
194. Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:196-200. (Pubitemid 27293188)
195. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001;27:355-362
196. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-acquired Pneumonia Study Group. Intensive Care Med 1996;22:387-394
197. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29: 1109-1115
198. Namias N, Samiian L, Nino D, et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 2000;49:638-645
199. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Am J Respir Crit Care Med 2000;162:837-843
200. Dellit TH, Chan DJ, Skerrett SJ, Nathens AB. Development of a guideline for the management of ventilator associated pneumonia based on local microbiolgic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008;29:525-533
201. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596
202. Croce MA, Fabian T, Waddle-Smith L, et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998;227: 743-751
203. Allaouchiche B, Jaumain H, Chassard D, Boulétreau P. Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia. Br J Anaesth 1999;83: 845-849
204. Davis KA, Eckert MJ, Reed RL II, et al. Ventilator-associated pneumonia in injured patients: do you trust your Gram's stain? J Trauma 2005;58:462-6; discussion 466-467
205. Feldman C, Kassel M, Cantrell J, et al. The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J 1999;13: 546-551
206. Adair CG, Gorman S, Feron BM, et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999;25:1072-1076
207. Kollef M. Epidemiology and risk factors for nosocomial pneumonia. Emphasis on prevention. Clin Chest Med 1999; 20:653-670
208. Olson ME, Harmon BG, Kollef MH. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 2002;12: 863-870
209. Rello J, Kollef M, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med 2006;34:2766-2772
210. Craven DE. Ventilator-associated tracheobronchitis (VAT): questions, answers, and a new paradigm? Crit Care 2008;12: 157.
211. Prats E, Dorca J, Pujol M, et al. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J 2002;19:944-951
212. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993;147:38-44.
213. Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 1998;26:236-244
214. Hubmayr RD, Burchardi H, Elliot M, et al; American Thoracic Society Assembly on Critical Care; European Respiratory Society; European Society of Intensive Care Medicine; Societe de Reanimation de Langue Francaise. Statement of the 4th International Consensus Conference in Critical Care on ICU-acquired pneumonia-Chicago, Illinois, May 2002. Intensive Care Med 2002;28:1521-1536
215. Berenholtz SM, Pronovost PJ, Ngo K, et al; Core Sepsis Measurement Team. Developing quality measures for sepsis care in the ICU. Jt Comm J Qual Patient Saf 2007;33: 559-568
216. Pieracci FM, Barie PS. Strategies in the prevention and management of ventilator-associated pneumonia. Am Surg 2007; 73:419-432
217. Rello J, Paiva JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001;120: 955-970
218. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes. A strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1040-1048
219. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29:1101-1108
220. Gruson D, Hilbert G, Vargas F, et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003;31:1908-1914
221. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004;125:1791-1799
222. Mueller E, Croce M, Boucher B, et al. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilatorassociated pneumonia. J Trauma 2007;63:1329-37; discussion 1337.
223. Dennesen PJ, Van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after microbial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001;163:1371-1375
224. Chastre J, Wolff M, Fagon JY, et al; PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilatorassociated pneumonia in adults: a randomized trial. JAMA 2003;290:2588-2598
225. Balis E, Diacaki C, Tselioti P, et al. Community-acquired pneumonia and bacteremia due to methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin gene in Greece: two case reports and literature review. J Chemother 2007;19:703-708
226. Chastre J. Evolving problems with resistant pathogens. Clin Microbiol Infect 2008;14:3-14.
227. Vidaur L, Planas K, Sierra R, et al. Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resources utilization. Chest 2008;133:625-632
228. CioffiWGJr, Rue LW III, Graves TA, McManus WF, Mason AD Jr, Pruitt BA Jr. Prophylactic use of high-frequency percussive ventilation in patients with inhalation injury. Ann Surg 1991;213:575-580
229. Cioffi WG, deLemos RA, Coalson JJ, Gerstmann DA, Pruitt BA Jr. Decreased pulmonary damage in primates with inhalation injury treated with high-frequency ventilation. Ann Surg 1993;218:328-335
230. Saffle JR, Morris SE, Edelman L. Early tracheostomy does not improve outcome in burn patients. J Burn Car Rehabil 2002;23:431-438
231. Barret JP, Desai MH, Herndon DN. Effects of tracheostomies on infection and airway complications in pediatric burn patients. Burns 2000;26:190-193
232. Gravvanis AI, Tsoutsos DA, Iconomou TG, Papadopoulos SG. Percutaneous versus conventional tracheostomy in burned patients with inhalation injury. World J Surg 2005; 29:1571-1575
233. Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008;45:293-298
234. Luyt CE, Combes A, Raynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008;34:1434-1440
235. Gibot S, Cravoisy A, Dupays R, et al. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 2007;39:604-608
236. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005;171:48-53.
237. Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D, Allaouchiche B. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002;96:74-79
238. Brown RB, Kruse JA, Counts GW, Russell JA, Christou NV, Sands ML. Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group. Antimicrob Agents Chemother 1990;34:269-272
239. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008;36:2008-2013
240. Claridge J, Edwards N, Swanson J, et al. Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study. Surg Infect (Larchmt) 2007;8:83-90.
241. Bodi M, Diaz E, Rello J. Appropriate antibiotic treatment for pneumonia. Clin Infect Dis 2000;31:1313-1314
242. Wysocki M, Thomas F, Wolff MA, Pean Y, Ravaud Y, Herman B. Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections. J Antimicrob Chemother 1995;35:352-354
243. Rubenstein E, Cammarata S, Oliphant T, Wunderink R; Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU- 100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized doubleblind multicenter study. Clin Infect Dis 2001;32:402-412
244. Kollef M. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627-634
245. Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000; 26:1239-1247
246. Rouby JJ, Laurent P, Gosnach M, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med 1994;150:776-783
247. Bach A, Boehrer H, Schmidt H, Geiss HK. Nosocomial sinusitis in ventilated patients. Nasotracheal versus orotracheal intubation. Anaesthesia 1992;47:335-339
248. Salord F, Lopez F, Gaussorgues P, et al. Nosocomial maxillary sinusitis during mechanical ventilation: a prospective comparison of orotracheal versus the nasotracheal route for intubation. Intensive Care Med 1990;16:390-393
249. Heyland DK, Dhaliwal R, Drover JW, et al; Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Perenter Enteral Nutr 2003;27:355-373
250. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on nosocomial pneumonia. Intensive Care Med 1993;19:256-264
251. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993;104: 1230-1235
252. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343-349
253. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-528
254. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792-796
255. Joshi N, Localio A, Hamory BH. A predictive risk index for nosocomial pneumonia in the intensive care unit. Am J Med 1992;93:135-142
256. Antonelli M, Moro ML, Capelli O, et al. Risk factors for early onset pneumonia in trauma patients. Chest 1994;105: 224-228
257. Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Pieper CF, Rutala WA. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996;153:158-162
258. Daschner F, Kappstein I, Engels I, et al. Stess ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents? Infect Control Hosp Epidemiol 1988; 9:59-65.